Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCβ-selective inhibitors

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 8.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation.

Toyoshi Inoguchi, Ruggero Battan, Eugene S. Handler et al. · Proceedings of the National Academy of Sciences · 1992 · 740 citations

Life Sciences, Biochemistry, Endocrinology +14

Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor

Lloyd Paul Aiello, Sven–Erik Bursell, Allen C. Clermont et al. · Diabetes · 1997 · 669 citations

Medicine, Ophthalmology, Pharmacology +15

(<i>S</i>)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1<i>H</i>,13<i>H</i>-dibenzo[<i>e</i>,<i>k</i>]pyrrolo[3,4-<i>h</i>][1,4,13]oxadiazacyclohexadecene-1,3(2<i>H</i>)-dione (LY333531) and Related Analogues:  Isozyme Selective Inhibitors of Protein Kinase Cβ

Michael R. Jirousek, James R. Gillig, Cécile Gonzalez et al. · Journal of Medicinal Chemistry · 1996 · 338 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes

Katherine R. Tuttle, George L. Bakris, Robert D. Toto et al. · Diabetes Care · 2005 · 301 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17